These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34323542)

  • 21. Mix and Match: An Investigation into Whether Episodic Future Thinking Cues Need to Match Discounting Delays in Order to Be Effective.
    O'Donnell S; Hollis-Hansen K; Epstein LH
    Behav Sci (Basel); 2018 Dec; 9(1):. PubMed ID: 30577671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Art-delivered episodic future thinking reduces delay discounting: A phase IIa proof-of-concept trial.
    Hudson JE; Grunevski S; Sebelius J; Yi R
    J Subst Use Addict Treat; 2024 Mar; 158():209255. PubMed ID: 38081541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.
    Kimmick G; Edmond SN; Bosworth HB; Peppercorn J; Marcom PK; Blackwell K; Keefe FJ; Shelby RA
    Breast; 2015 Oct; 24(5):630-6. PubMed ID: 26189978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mixed-methods study of the technical feasibility and patient acceptability of a real-time adherence monitor in breast cancer survivors taking adjuvant endocrine therapy.
    Bright EE; Genung SR; Stanton AL; Arch JJ
    Breast Cancer Res Treat; 2022 Oct; 195(3):393-399. PubMed ID: 35962148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Good adherence to adjuvant endocrine therapy in early breast cancer - a population-based study based on the Swedish Prescribed Drug Register.
    Lundgren C; Lindman H; Rolander B; Ekholm M
    Acta Oncol; 2018 Jul; 57(7):935-940. PubMed ID: 29493327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do process simulations during episodic future thinking enhance the reduction of delay discounting for middle income participants and those living in poverty?
    O'Donnell S; Daniel TO; Koroschetz J; Kilanowski C; Otminski A; Bickel WK; Epstein LH
    J Behav Decis Mak; 2019 Jul; 32(3):231-240. PubMed ID: 34334945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant therapy use among Appalachian breast cancer survivors.
    Tan X; Marshall VD; Anderson RT; Donohoe J; Camacho F; Balkrishnan R
    Medicine (Baltimore); 2015 Jul; 94(26):e1071. PubMed ID: 26131828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
    Wassermann J; Gelber SI; Rosenberg SM; Ruddy KJ; Tamimi RM; Schapira L; Borges VF; Come SE; Meyer ME; Partridge AH
    Cancer; 2019 Sep; 125(18):3266-3274. PubMed ID: 31120571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study.
    Wells KJ; Pan TM; Vázquez-Otero C; Ung D; Ustjanauskas AE; Muñoz D; Laronga C; Roetzheim RG; Goldenstein M; Carrizosa C; Nuhaily S; Johnson K; Norton M; Sims E; Quinn GP
    Support Care Cancer; 2016 Oct; 24(10):4123-30. PubMed ID: 27146492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Episodic Future Thinking about Smoking-Related Illness: A Preliminary Investigation of Effects on Delay Discounting, Cigarette Craving, and Cigarette Demand.
    Ruhi-Williams P; King MJ; Stein JS; Bickel WK
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Think fast: rapid assessment of the effects of episodic future thinking on delay discounting in overweight/obese participants.
    Stein JS; Sze YY; Athamneh L; Koffarnus MN; Epstein LH; Bickel WK
    J Behav Med; 2017 Oct; 40(5):832-838. PubMed ID: 28508382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials.
    Brown JM; Bickel WK; Epstein LH; Stein JS
    PLoS One; 2023; 18(8):e0289478. PubMed ID: 37535609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
    Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK
    Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Written or drawn episodic future thinking cues improves delay discounting in adults.
    Carr KA; Hollis-Hansen K; Austin K; Epstein LH
    Learn Motiv; 2021 May; 74():. PubMed ID: 36425115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients.
    Jacob Arriola KR; Mason TA; Bannon KA; Holmes C; Powell CL; Horne K; O'Regan R
    Patient Educ Couns; 2014 Apr; 95(1):98-103. PubMed ID: 24492157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Episodic future thinking for smoking cessation in individuals with substance use disorder: Treatment feasibility and acceptability.
    Aonso-Diego G; González-Roz A; Martínez-Loredo V; Krotter A; Secades-Villa R
    J Subst Abuse Treat; 2021 Apr; 123():108259. PubMed ID: 33612193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine therapy for breast cancer: assessing an array of women's treatment experiences and perceptions, their perceived self-efficacy and nonadherence.
    Wouters H; Stiggelbout AM; Bouvy ML; Maatman GA; Van Geffen EC; Vree R; Nortier JW; Van Dijk L
    Clin Breast Cancer; 2014 Dec; 14(6):460-467.e2. PubMed ID: 24981234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of episodic future thinking on reinforcement pathology during smoking cessation treatment among individuals with substance use disorders.
    García-Pérez Á; Aonso-Diego G; Weidberg S; Secades-Villa R
    Psychopharmacology (Berl); 2022 Feb; 239(2):631-642. PubMed ID: 35020047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer.
    Corter AL; Broom R; Porter D; Harvey V; Findlay M
    Psychooncology; 2018 Sep; 27(9):2096-2103. PubMed ID: 29776011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of symptom clusters on endocrine therapy adherence in patients with breast cancer.
    Agnew S; Crawford M; MacPherson I; Shiramizu V; Fleming L
    Breast; 2024 Jun; 75():103731. PubMed ID: 38599048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.